SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-032166
Filing Date
2020-03-12
Accepted
2020-03-12 07:55:10
Documents
77
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tm206796d1_20f.htm 20-F 1536188
2 EXHIBIT 2.1 tm206796d1_ex2-1.htm EX-2.1 61992
3 EXHIBIT 4.6 tm206796d1_ex4-6.htm EX-4.6 12185
4 EXHIBIT 8.1 tm206796d1_ex8-1.htm EX-8.1 4406
5 EXHIBIT 12.1 tm206796d1_ex12-1.htm EX-12.1 8211
6 EXHIBIT 12.2 tm206796d1_ex12-2.htm EX-12.2 8147
7 EXHIBIT 13.1 tm206796d1_ex13-1.htm EX-13.1 6224
8 EXHIBIT 15.1 tm206796d1_ex15-1.htm EX-15.1 3010
15 GRAPHIC image_002.jpg GRAPHIC 9262
16 GRAPHIC image_004a.jpg GRAPHIC 61958
17 GRAPHIC tm206796-1_20fimg01.jpg GRAPHIC 10271
18 GRAPHIC tm206796-1_20fimg02.jpg GRAPHIC 25696
19 GRAPHIC tm206796-1_fimg1.jpg GRAPHIC 29011
20 GRAPHIC tm206796-1_fimg2.jpg GRAPHIC 21920
21 GRAPHIC tm206796-1_fimg4.jpg GRAPHIC 44993
  Complete submission text file 0001104659-20-032166.txt   5819087

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT glmd-20191231.xml EX-101.INS 1159181
10 XBRL TAXONOMY EXTENSION SCHEMA glmd-20191231.xsd EX-101.SCH 37170
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glmd-20191231_cal.xml EX-101.CAL 47861
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glmd-20191231_def.xml EX-101.DEF 106065
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE glmd-20191231_lab.xml EX-101.LAB 294801
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glmd-20191231_pre.xml EX-101.PRE 254657
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 20707186
SIC: 2834 Pharmaceutical Preparations